Vietnam Pharmacy chains: key facts

Last updated 2026-11-11 · 8 sourced answers from KIRA RESEARCH reports and field research. Every figure shows its year and source.

Channels and distribution

Who gets the money when a drug maker pays a pharmacy chain for shelf priority in Vietnam?

In other Asian markets, practitioners report priority-list deals are signed with chain headquarters, not clerks, and rebates flow back to stores through bonuses, per KIRA field research (interviews with pharmacy chain managers, pharmacists and drug maker staff in another large Asian market).

Source: KIRA field research (modelled interview) · Why the pharmacist recommends a different brand: priority lists, rebates and bonuses behind the counter in Vietnam's pharmacy chains

Margins

Why are pharmacy chains' margins under pressure in Vietnam?

Practitioners say a loss-making chain checks the margin on every box; An Khang lost $13.88 million in 2024 (Vietnam Investment Review, 27 Mar 2025), as cited in KIRA field research (interviews with pharmacy chain managers, pharmacists and drug maker staff in another large Asian market).

Source: KIRA field research (modelled interview), 2024 · Why the pharmacist recommends a different brand: priority lists, rebates and bonuses behind the counter in Vietnam's pharmacy chains

Regulation

Can a pharmacy chain sell prescription drugs online in Vietnam?

Practitioners say the counter stays where prescription drugs are sold because online retail of them is prohibited, per KIRA field research (interviews with pharmacy chain managers, pharmacists and drug maker staff in another large Asian market).

Source: KIRA field research (modelled interview) · Why the pharmacist recommends a different brand: priority lists, rebates and bonuses behind the counter in Vietnam's pharmacy chains

Can a drug maker offer a pharmacy chain a rebate in Vietnam under the 2025 rules?

Practitioners read the ban as aimed at offers to prescribers, not chain purchase prices; treat that reading as unverified, per KIRA field research (interviews with pharmacy chain managers, pharmacists and drug maker staff in another large Asian market).

Source: KIRA field research (modelled interview) · Why the pharmacist recommends a different brand: priority lists, rebates and bonuses behind the counter in Vietnam's pharmacy chains

Market entry

How does a local drug maker get onto a pharmacy chain's priority list?

In other Asian markets, practitioners report local makers enter through one-year top-priority deals with major chains, renewed each year, per KIRA field research (interviews with pharmacy chain managers, pharmacists and drug maker staff in another large Asian market).

Source: KIRA field research (modelled interview) · Why the pharmacist recommends a different brand: priority lists, rebates and bonuses behind the counter in Vietnam's pharmacy chains

Where should a new drug maker start when entering Vietnam's pharmacy chains?

Practitioners say start at headquarters, because priority lists, rebates and targets cascade from there to stores, per KIRA field research (interviews with pharmacy chain managers, pharmacists and drug maker staff in another large Asian market).

Source: KIRA field research (modelled interview) · Why the pharmacist recommends a different brand: priority lists, rebates and bonuses behind the counter in Vietnam's pharmacy chains

How the trade works

What drives a pharmacist to recommend a different brand at a Vietnamese pharmacy chain counter?

In other Asian markets, practitioners report pharmacists usually start brand switches, because monthly bonus and per-box reward drive behaviour, per KIRA field research (interviews with pharmacy chain managers, pharmacists and drug maker staff in another large Asian market).

Source: KIRA field research (modelled interview) · Why the pharmacist recommends a different brand: priority lists, rebates and bonuses behind the counter in Vietnam's pharmacy chains

What should a drug maker offer a pharmacy chain counter to win shelf share?

In other Asian markets, practitioners report makers win with conditional rebates tied to sell-out, trained counter staff and packaging patients recall, not unconditional discounts, per KIRA field research (interviews with pharmacy chain managers, pharmacists and drug maker staff in another large Asian market).

Source: KIRA field research (modelled interview) · Why the pharmacist recommends a different brand: priority lists, rebates and bonuses behind the counter in Vietnam's pharmacy chains

Who decides

Practitioner views from KIRA Experts transcripts: modelled interviews built on KIRA's field interviews. How we work: Methodology.

Who specifies

  • Drug makers agree priority-list deals with chain headquarters, which receives the rebates and returns them to stores through bonuses and group targets. pharmacy chain store managers · KIRA field research (interviews with pharmacy chain managers, pharmacists and drug maker staff in another large Asian market)

Who buys and pays

  • Headquarters is the commercial control point of a pharmacy chain, so the head-office deal and staff incentives decide brand choice more than patient preference for most chronic drugs. pharmacy chain store managers · KIRA field research (interviews with pharmacy chain managers, pharmacists and drug maker staff in another large Asian market)
  • Pharmacists at the counter usually start a brand switch, because their low fixed salary makes monthly bonuses and per-box rewards the real motivation. pharmacy chain store managers · KIRA field research (interviews with pharmacy chain managers, pharmacists and drug maker staff in another large Asian market)

Who carries the risk

No field statement yet

How the trade works

Practitioner views from KIRA Experts transcripts: modelled interviews built on KIRA's field interviews. How we work: Methodology.